Cardiovascular outcomes of SGLT2 inhibition: evidence from recent clinical trials.
Session:
Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes
Topic:
Chronic heart failure
Speaker:
Doctor D. Fitchett (Toronto, CA)
Organised by the Physicians Academy for Cardiovascular Education (PACE) Foundation / Course Director: Prof Adriaan A Voors / Supported by an unrestricted educational grant from Boehringer Ingelheim
Event:
HEART FAILURE 2016
Congress Presentation
About the speaker
Doctor David Fitchett
St. Michael's Hospital, Toronto (Canada)
18
presentations
0
follower
2 more presentations in this session
Interactive case discussion: what are the clinical implications of cardiovascular outcomes of SGLT2 inhibition?
Speaker: Professor S. Anker (Berlin, DE) Doctor D. Fitchett (Toronto, CA)
Access the full session
Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes
Speakers:
Doctor D. Fitchett, Professor S. Anker, Professor S. Anker, Doctor D. Fitchett
About the event
ESC 365 is supported by
